Alleles of tumor necrosis factor-a (TNF-a) gene have been inconsistently associated with systemic lupus erythematosus (SLE), particularly the 308-A/G functional promoter polymorphism. To generate large-scale evidence on whether 308-A/G promoter polymorphism is associated with SLE susceptibility we have conducted a meta-analysis. We have identified 21 studies of this polymorphism and SLE using MEDLINE search. Meta-analysis was performed for genotypes A/A (recessive effect), A/A þ A/G (dominant effect), and A allele in fixed or random effects models. All control samples were in Hardy -Weinberg proportion. The overall odds ratio (OR) of the A/A genotype was 3.2 (95% CI ¼ 2.0 -5.3, Po0.001). Stratification by ethnicity indicated that the A/A genotype was associated with SLE in European-derived population (OR ¼ 4.0, CI ¼ 2.5-6.4, Po0.001). No association was detected in Asian-derived population (OR, 1.3, CI ¼ 0.3 -6.3, P ¼ 0.76). The overall OR for the risk genotypes (A/A and A/G) was 2.0 (CI ¼ 1.3 -3.1, Po0.001). Similar results were found between the risk allele A and SLE where a significant association was found in European population (OR ¼ 2.1, CI ¼ 1.6 -2.7, Po0.001), but not in Asian (OR ¼ 1.4, CI ¼ 0.8 -2.3, P ¼ 0.2) or African (OR ¼ 1.2, CI ¼ 0.6 -2.5, P ¼ 0.59) populations. In summary, this meta-analysis demonstrates that the TNF-a promoter À308 A/G polymorphism may confer susceptibility to SLE, especially in European-derived population.
Introduction
Systemic lupus erythematosus (SLE) is a disorder of generalized autoimmunity, characterized by multisystemic organ involvement, polyclonal B-cell activation and the production of autoantibodies. Significant familial aggregation, convincing demonstration of multiple genetic linkage and associations with SLE demonstrate an underlying genetic basis of the disease.
1,2 However, many genes probably interact with each other and with the environment in a multifaceted way, making identification of any gene difficult. 3 Genes involved in potentially disease generating biological mechanisms are ideal candidates for genetic etiological involvement. Multiple genetic associations have been identified, suggesting involvement of major histocompatibility complex (MHC) in susceptibility to SLE. Tumor necrosis factora (TNF-a) gene is located on chromosome 6, within the class III region of MHC. 4 TNF-a is a potential proinflammatory cytokine that plays an important role in inflammatory and immune responses. 5 TNF-a stimulates cytokine production, enhancing expression of adhesion molecules and neutrophil activation and acts as a costimulator for T-cell activation and antibody production. It is unclear as to whether the role of TNF-a as a mediator of inflammation is a beneficial or deleterious one in the susceptibility to SLE. Involvement in SLE has been suggested by findings from the experiments on human SLE and animal models. For example, TNF-a levels are increased in SLE patients compared with controls and strongly correlate with SLE activity. 6 The minor allele at À308 base pairs from the transcription initiation site in the promoter of TNF-a (TNF-a À308 A or TNF-a2) has been associated with production of TNF-a and susceptibility to SLE. 7 -13 However, many studies have shown inconclusive or contradictory results. This inconsistency may be due to studies with inadequate statistical power, racial and ethnic differences, publication bias, or uncorrected multiple hypothesis testing. Although it is unclear whether the TNF-a promoter À308 A/G polymorphism has a functional significance, several evidences suggest that there may be a small but significant effect of the TNF-a promoter À308 A/G polymorphism, with the A allele being associated with slightly greater levels of TNF-a transcription.
14 Meta-analysis is a statistical procedure for combining results from several studies to produce a single estimate of the major effect with enhanced precision. 15 One of the major advantages of meta-analysis is to increase sample size, which may reduce the probability that random error will produce false-positive or false-negative associations. Therefore, meta-analysis is an ideal and powerful tool for summarizing the inconsistent results from different studies. The aim of the present study was to investigate whether the TNF-a promoter À308 A/G polymorphism is a risk factor to the SLE susceptibility, using a meta-analysis.
Methods
Identification of eligible studies and data extraction We performed an exhaustive search on studies that examined the association of the TNF-a promoter À308 A/G polymorphism with SLE. A search of the literature was made using MEDLINE citation to identify available articles in which the TNF-a promoter À308 A/G polymorphism was determined in SLE patients and control (most recent one was May 2005) . References in the studies were reviewed to identify additional studies not indexed by MEDLINE. 'Tumor necrosis factor', 'TNF-a', 'polymorphism', SLE, and 'systemic lupus erythematosus' were entered as both medical subject heading (MeSH) terms and text words. No language restrictions were applied. A study was included in the analysis if (1) it was published up to March 2004, (2) it was original data (independence among studies), and (3) it provided enough data to calculate odds ratio (OR). When a study reported the results on different subpopulation, we treated them as a separate study in the meta-analysis. We excluded the following: (1) studies that contained overlapping data, (2) studies in which the number of null and wild genotypes could not be ascertained, and (3) studies in which family members had been studied because their analysis is based on linkage considerations. From each study, we extracted the available genotype and allele frequency information from the TNF-a promoter À308 A/G polymorphism.
Evaluation of publication bias
A funnel plot has been used in order to assess the publication bias. 16 However, the funnel plot is no longer considered strictly as a test of publication bias. All studies were of relatively small sample size with no large differences in the standard errors of the lnOR estimates, therefore it would not make much sense to examine whether larger studies differed from smaller ones.
Evaluation of the statistical association Allele frequencies at the TNF-a promoter À308 A/G polymorphism from the respective study were determined by the allele counting method. A w 2 -test was used to determine if observed frequencies of genotypes conformed to Hardy -Weinberg (H -W) expectations. We also tested for H -W proportion separately for each race-specific pools.
We examined the contrast of the allelic effect of A (minor allele) versus G (common allele), and also examined the contrast of A/A versus A/G þ G/G genotypes as well as the contrast of A/A þ A/G versus G/G genotypes. These contrasts correspond to the recessive and dominant effects of the A allele, respectively. The point estimates of the risk, the OR, and its 95% confidence interval (CI) were estimated for each study. We assessed the within-and between-study variation or heterogeneity by testing Cochran's Q-statistic. 17 This heterogeneity test assessed the null hypothesis that all studies were evaluating the same effect. A significant Q-statistic (Po0.10) indicated heterogeneity across studies, and then the random effect model was used for meta-analysis. Otherwise, the fixed effect model was used. Fixed effect model assumes all of the studies are estimating the same underlying effect and considers only within-study variation. We also quantified the effect of heterogeneity using a recently developed measure, I 2 ¼ 100% Â (QÀdf)/Q. 18 The I 2 -statistic measures the degree of inconsistency in the studies by calculating what percentage of the total variation across studies is due to heterogeneity rather than by chance. Finally, the overall or pooled estimate of risk (OR) was obtained by using Peto's method in the fixed effect model 19 and by DerSimonian and Laid method in the random effect model. 20 Pooled OR in the meta-analysis was performed weighting individual OR by the inverse of their variance. We also estimated the expected power of each individual study as determined by the probability of detecting a true association between TNF-a À308 A/G polymorphism and SLE at the 0.05 level of significance, assuming OR of 1.5 and 2.0 for differences in allele frequency, and the minor (disease) allele frequency is of 0.2. The power was estimated on the basis of the method described earlier. 21 Statistical manipulations for the metaanalysis were undertaken using program EasyMA (http://www.spc.univ-lyon1.fr/easyma/download.htm).
Results

Studies included in the meta-analysis
The literature search identified 59 potentially relevant publications. Among them, 40 studies were excluded because they did not meet the inclusion criteria. They were studies on other TNF polymorphism such as TNF receptor genes (19 publications), studies on other diseases (16 publications) or animal studies (four publications) or family study (one publication). There were no studies in which the number of null and wild genotypes could not be ascertained. A total of 19 relevant studies with TNF-a promoter À308 A/G polymorphism and SLE were selected for the meta-analysis. Evaluation of study quality The distribution of the genotype in control group in Europeans, Asians and Africans was consistent with H -W equilibrium (European, P ¼ 0.59; Asian, P ¼ 0.76; African,
Evaluation of A/G polymorphism and SLE association Selected characteristics of 21 case-control studies for TNF-a À308-A/G polymorphism and the risk of SLE are summarized in Table 1 . Also, Table 1 shows the expected power of each individual study to demonstrate an association between this polymorphism and SLE. Interestingly, none of the 21 individual studies demonstrated a reasonable statistical power to detect the association ( Table 1) . The ORs with 95% CI of individual studies for the association of the A allele at the TNF-a locus and SLE are TNF-a meta-analysis for SLE YH Lee et al shown in Table 1 . The summary of meta-analysis for the TNF-a promoter À308 polymorphism with SLE is shown ( Table 2 ). The Q-test of heterogeneity was almost always significant and we conducted analyses using random effect models except in one case which was in a subgroup analysis and the Q-test was likely to have been not statistically significant owing to lack of power. So we also performed the subgroup analysis using random effect model. An association between SLE and A/A risk genotype (assuming A allele as recessive allele) was found in the overall population (OR ¼ 3.2, 95% CI ¼ 2.0 -5.3, Po0.001) (Figure 1 ). However, stratification by ethnicity indicates that the A/A genotype is significantly associated with SLE in Europeans (OR ¼ 4.0, 95% CI ¼ 2.5 -6.4, Po0.001). Conversely, there was no association detected for the A/A genotype with SLE patients from the Asian samples (OR ¼ 1.3, 95% CI ¼ 0.3 -6.3, P ¼ 0.76). Genotype data on TNF-a À308 A/G polymorphism was available for one of three studies in African population, 30 Figure 1 ). Stratification by ethnicity indicates that the A allele is a risk factor for SLE in European (OR ¼ 2.1, 95% CI ¼ 1.6 -2.7, Figure 2) . We also performed a 'model-free' analysis by considering the G/G genotype as the reference and estimated the OR for the A/A versus G/G and A/G versus G/G genotype. We found gene dosage effect of the A allele (Table 2) . Overall, the meta-analysis of the TNF-a À308 A/A genotype (recessive effect), A/A þ A/G genotype (dominant effect), and the risk allele A was associated with susceptibility of SLE in Europeans.
Discussion
TNF-a is an inducible cytokine with a broad range of proinflammatory and immuno-stimulatory actions. 5 The importance of TNF-a in the pathogenesis of SLE is unclear but even minor differences in TNF-a production can influence upon the resulting autoimmune disease. In mice, lupusprone strains have been shown to have different phenotypes. The (NZB X NZW) F1 strain of genetic murine lupus produces relatively low level of TNF-a. Therapy with recombinant TNF-a caused a significant delay in the onset of nephritis and an improved survival rate. 36 In contrast, the MRL-lpr/lpr and BXSB strains of murine lupus produce relatively high TNF-a levels. 37 The increase of TNF-a in SLE and the development of antinuclear antibodies and anti-DNA antibodies, and an SLE-like illness in some patients treated with TNF antagonists lead some to suspect that the TNF-a axis may be important in susceptibility. TNF-a meta-analysis for SLE YH Lee et al TNF-a is located within the MHC class III region in chromosome 6p21.3. The TNF-a A/G polymorphism has been reported to be associated with several autoimmune disorders including SLE. 7, 27, 40 However, studies of an association of TNF-a A/G polymorphism with SLE have reported conflicting results ( Table 1) . The most obvious explanation is that individual studies have not had sufficient statistical power to detect the small differences between cases and controls, and that is reflected from our power analysis. None of the 21 individual studies has shown a statistical power greater than 80% to detect the association between TNF-a À308 A/G polymorphism and SLE. Meta-analysis is a method to integrate previous research, providing increased statistical power and resolution by combining the results of independent analyses. Metaanalysis is a promising method to overcome the problem of small sample size and inadequate statistical power of TNF-a meta-analysis for SLE YH Lee et al genetic studies of complex traits. Our meta-analysis showed significant susceptibility from this TNF-a À308 promoter G/A polymorphism in the overall population samples. Subsequently, a meta-analysis after stratification by ethnicity detected a significant association with the TNF-a polymorphism in the European-derived samples, but not in Asian-derived or African-derived samples according to the allele-based comparisons of the 21 studies. The available data support TNF-a À308 A/G polymorphism being an ethnic population-specific risk factor for SLE, although the small number of Asian-derived and Africanderived studies available to date reduces our confidence in this conclusion. The finding of the different association according to ethnicity is somewhat surprising. It needs to be explained why the TNF-a promoter À308 A allele is not associated with SLE in non-European populations, especially Asian population. Ioannidis et al revealed that the frequencies of the genetic marker of interest in the control population (58%) often showed large heterogeneity between races. Conversely, they saw large heterogeneity in the genetic effects between races in only 14% of cases. 41 Our finding might be partially explained by ethnic difference. The allele-based comparisons show results that have absolutely no racial heterogeneity and the 95% CIs amply overlap. I 2 for the between-racial descent heterogeneity were quite small and nowhere near statistical difference (data not shown). The present study may have three caveats. First, cases and controls in the studies contributing to this metaanalysis were not age-and sex-matched, with the exception of two studies. 10, 34 Provided that the ethnic background is similar among patients and controls and the frequency of the polymorphism does not change with age among controls, the lack of matching by age should not introduce bias. Second, our study identified a stronger association between the disease causing allele or carrier genotypes and SLE, especially in the patients with the European-derived population. However, the lack of association in the Asian-derived and African-derived populations from this study might not be very conclusive owing to the relatively small number of Asian-derived and African-derived populations used in the analysis. Third, 10 European studies found a formally statistically significant effect on their own, although none of the studies had enough power to detect an effect that would be plausible. This may be indirect evidence that some selective reporting bias is operating here, and it may be quite substantial. There has been controversy whether the TNF-a promoter À308 A/G polymorphism has a functional significance. The construct with TNF-a promoter containing the À308 A allele produced up to six times more mRNA than that with À308 G allele, 40 though this has not been a consistent findings. 42, 43 Five of six previous studies observed higher levels of production of TNF-a by cells of À308 A/G individuals than cells of À308 G/G individuals. The degree of increase was generally approximately 20 -40% and whether or not the result was considered to be significant appeared to be related to the number of individuals tested, 14 suggesting that this polymorphism may be associated with a small but significant increase in gene transcription. Our findings are likely to favor the functional studies that the A allele of the TNF-a À308 is susceptible to autoimmune diseases including SLE. Our results seem to support the idea that TNF-a may be detrimental in SLE, by both inducing inflammation and apoptosis, which could fuel the autoimmune response. The region spanning the TNF cluster has been implicated in susceptibility to numerous immunopathological diseases, including SLE. Recently, using the ancestral recombinants information, Graham et al 44 demonstrated that the disease-associated haplotypes in HLA class II region containing DRB1 and DQB1 alleles were strong risk factors for human SLE. However, possible linkage disequilibrium across the HLA region has hampered the identification of the precise genes involved. The class III region of HLA including TNF-a lies between the class I and II regions and contains genes important for the innate immune system, including the complement components C2 and C4. The TNF-a promoter À308 A allele and HLA_DR alleles contributed independently to susceptibility to SLE in South African patients, 33 whereas the TNF-a A allele was in linkage disequilibrium with the HLA-DR3 allele in Caucasian SLE patients. 13 Therefore, whether TNF-a alone and/or in combination with the other genes in this region is conferring the susceptibility to lupus is unknown, and this is beyond the scope of the present study. Previous two meta-analyses of FcgRIIa and FcRgIIa in SLE have shown a modest relative risk for SLE. 45, 46 A metaanalysis of 17 studies has concluded that the low-binding R131 allele confers a 1.3-fold risk for developing SLE 45 and a meta-analysis of more than 1000 subjects has concluded that the F158 allele confers a 1.2-fold risk for developing lupus nephritis. 46 Taken together, it is suggested that multiple susceptibility genes with small or modest effect contribute to the development of SLE.
38,39
In conclusion, combined results of independent association studies by meta-analysis showed significant association between disease susceptible allele 'A', A/A genotype and A/A þ A/G genotype of the TNF-a À308 A/G polymorphism and SLE. The race-specific meta-analysis demonstrates a significant statistical association with European-derived samples but not with Asian or Africanderived samples. Therefore, our meta-analysis demonstrates that the TNF-a À308 A/G polymorphism may be a risk factor for SLE, especially in those with European ancestry.
